Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Debt / NOTE 0.125%12/1
-
Market price (% of par)
-
92.92%
-
Total 13F principal
-
$512,971,856
-
Principal change
-
-$26,953,977
-
Total reported market value
-
$476,527,327
-
Number of holders
-
43
-
Value change
-
-$26,423,228
-
Number of buys
-
17
-
Number of sells
-
18
Institutional Holders of IONIS PHARMACEUTICALS INC - NOTE 0.125%12/1 as of Q2 2021
As of 30 Jun 2021,
IONIS PHARMACEUTICALS INC - NOTE 0.125%12/1 was held by
43 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$512,971,856
in principal (par value) of the bond.
The largest 10 bondholders included
DeepCurrents Investment Group LLC, TENOR CAPITAL MANAGEMENT Co., L.P., D. E. Shaw & Co., Inc., Opti Capital Management, LP, STEELHEAD PARTNERS LLC, CAMDEN ASSET MANAGEMENT L P /CA, Verition Fund Management LLC, PFM Health Sciences, LP, CALAMOS ADVISORS LLC, and Polar Capital Holdings Plc.
This page lists
43
institutional bondholders reporting positions
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.